2025. Deucravacitinib in Plaque Psoriasis: Immune Response to and Safety of Pneumococcus and Tetanus Toxoid Vaccines in the POETYK LTE Trial. SKIN The Journal of Cutaneous Medicine. 9, 2 (Mar. 2025), s534. DOI:https://doi.org/10.25251/skin.10.supp.534.